EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Efficacy of the natural antioxidant astaxanthin in the treatment of functional dyspepsia in patients with or without Helicobacter pylori infection: A prospective, randomized, double blind, and placebo-controlled study



Efficacy of the natural antioxidant astaxanthin in the treatment of functional dyspepsia in patients with or without Helicobacter pylori infection: A prospective, randomized, double blind, and placebo-controlled study



Phytomedicine 15(6-7): 391-399



The aim of this study was to evaluate the efficacy of the natural antioxidant astaxanthin in functional dyspepsia in different doses and compared with placebo. The study was a controlled, prospective, randomized, and double blind trial. Patients with functional dyspepsia, divided into three groups with 44 individuals in each group (placebo, 16mg, or 40mg astaxanthin, respectively). Participants were asked to accept gastroscopy before treatment, together with questionnaires: GSRS and SF-36. Urea breath test (UBT) was done before the treatment. The primary objective was to test the hypothesis that the antioxidant astaxanthin at two doses regimens compared to placebo should ameliorate gastrointestinal discomfort measured as GSRS in patients with functional dyspepsia, who were either positive or negative for Helicobacter pylori, after 4 weeks of treatment. At the end of therapy (week 4) no difference between the three treatment groups was observed regarding mean Gastrointestinal Symptom Rating Scale (GSRS) scores of abdominal pain, indigestion and reflux syndromes. The same results were observed at the end of follow-up. However reduction of reflux syndrome before treatment to week 4 was significantly pronounced in the higher (40mg) dose compared to the other treatment groups (16mg and placebo, p=0.04). In general, no curative effect of astaxanthin was found in functional dyspepsia patients. Significantly greater reduction of reflux symptoms were detected in patients treated with the highest dose of the natural antioxidant astaxanthin. The response was more pronounced in H. pylori-infected patients.

(PDF emailed within 0-6 h: $19.90)

Accession: 052904966

Download citation: RISBibTeXText

PMID: 18467083

DOI: 10.1016/j.phymed.2008.04.004



Related references

Efficacy of the natural antioxidant astaxanthin in the treatment of functional dyspepsia in patients with or without Helicobacter pylori infection: a prospective, randomized, double blind, and placebo-controlled study. Phytomedicine 15(6-7): 391-399, 2008

Efficacy of the natural antioxidant astaxanthin in the treatment of functional dyspepsia in patients with or without Helicobacter pylori infection a prospective, randomized, double blind, and placebo-controlled study. Phytomedicine: 6 7, 391-399, 2008

Failure of a Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of H. pylori Eradication in H. pylori-Infected Patients with Functional Dyspepsia. Gut and Liver 5(4): 468-471, 2011

Helicobacter pylori eradication for non-ulcer dyspepsia A prospective, double-blind, randomized, placebo controlled study. Gastroenterology 110(4 SUPPL ): A91, 1996

Efficacy of astaxanthin rich algal meal in the treatment of nonulcer dyspepsia A randomized double blind placebo controlled Study. Helicobacter 8(4): 472, August, 2003

H pylori eradication for functional dyspepsia A long-term, randomized, prospective, double-blind, placebo-controlled study. Gut 43(SUPPL 2): A81, Sept, 1998

Double-blind placebo-controlled multicentre studies of rebamipide, a gastroprotective drug, in the treatment of functional dyspepsia with or without Helicobacter pylori infection. Alimentary Pharmacology & Therapeutics 15(10): 1603-1611, October, 2001

Association of a probiotic to a Helicobacter pylori eradication regimen does not increase efficacy or decreases the adverse effects of the treatment: a prospective, randomized, double-blind, placebo-controlled study. Bmc Gastroenterology 13: 56-56, 2013

Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group. Bmj 318(7187): 833-837, 1999

Cure of Helicobacter pylori infection does not improve symptoms in non-ulcer dyspepsia patients-a double-blind placebo-controlled study. Alimentary Pharmacology & Therapeutics 14(3): 317-324, 2000

Clinical outcomes of eradication of Helicobacter pylori in nonulcer dyspepsia in a population with a high prevalence of infection: results of a 12-month randomized, double blind, placebo-controlled study. Digestive Diseases and Sciences 51(1): 89-98, 2006

Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: a prospective randomized placebo-controlled double-blind study. Helicobacter 12(4): 309-316, 2007

Absence of symptomatic benefit of lansoprazole, clarithromycin and amoxicillin triple therapy is cure of helicobacter pylori positive functional dyspepsia patients a randomized double blind placebo controlled trial. Digestive Disease Week Abstracts & Itinerary Planner : Abstract No S1257, 2003

Helicobacter pylori eradication in non-ulcer dyspepsia A randomized, double-blind, placebo-controlled study with a 12-month follow-up. Gastroenterology 118(4 Suppl 2 Part 1): AGA A468, April, 2000

Evaluation of the Safety and Efficacy of a Multienzyme Complex in Patients with Functional Dyspepsia: A Randomized, Double-Blind, Placebo-Controlled Study. Journal of Medicinal Food 21(11): 1120-1128, 2018